Link Pharma Chem Limited has informed the stock exchanges about receiving a GST demand order from tax authorities, disclosing significant financial implications under regulatory compliance requirements.

GST Demand Details

The Assistant Commissioner, Central GST & Central Excise, Vadodara has issued a demand order against the company for the financial year 2021-22. The order encompasses two primary components of tax demands and recoveries.

Nature of Violations

The tax authorities have identified specific contraventions in the company's GST compliance for the period 2021-22:

• Tax Declaration Mismatch: Discrepancy between tax liability declared in GSTR1 and tax paid through GSTR3B
• Excess ITC Claims: Excess Input Tax Credit availed on import of goods not reflected in GSTR-2A

Company Response and Impact

Link Pharma Chem received the demand order on January 27, 2026, and has made the disclosure in compliance with SEBI regulations. The company has assessed the financial impact as limited to the extent of the demand, penalty, and interest imposed, stating there is no material impact on its operations.

The pharmaceutical company has indicated its intention to file an appeal with the appropriate authority to contest the demand order. This legal recourse suggests the company disputes the findings of the tax authorities.

Regulatory Compliance

The disclosure was made under Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Managing Director Rishikesh Thakur signed the communication to BSE Limited, ensuring transparency with stakeholders regarding the regulatory development.

Link Pharma Chem Limited operates from its registered office in GIDC, Nandesari, Vadodara, Gujarat, and is engaged in pharmaceutical and chemical manufacturing activities.